Informacje dodatkowe
| Active substance | Drospirenone, Ethinyl Estradiol |
|---|---|
| Chemical name | (6R,7R,8R,9S,10S,13S,14S,15S,16S,17S)-1,3',4',6,6',7,8,9,10,13,14,15,16,17,17a-hexadecahydro-10,13-dimethylspiro-[17H-dicyclopropa[6,7:15,16]cyclopenta[a]phenanthrene-17,2'(5'H)-furan]-3,5'(2H)-dione |
| Side effects | Breast tenderness, headache, nausea, bloating, mood changes |
| Effects | Prevention of ovulation, increased cervical mucus viscosity |
| Dosage (sports) | Not applicable |
| Dosage (medical) | Commonly 3 mg/day in combination with ethinyl estradiol for contraception |
| Half-life | Approximately 30 hours |
| Main action | Progestogenic activity, anti-mineralocorticoid activity, and weak antiandrogenic activity |
| Substance class | Synthetic steroidal progestin |
| Formula | C24H30O3 |
| Storage conditions | Store at room temperature away from moisture and heat |
| Trade name | Yasmin, Yaz, others |
| Blood pressure | May increase slightly, monitor in patients with hypertension |
| Also known as | DRSP |
| Strength | 3/0.02mg |
| Lab Test | Not specific, but hormone levels can be monitored |
| Hepatotoxicity | Low |
| Water Retention | Low (due to anti-mineralocorticoid properties) |
| Use in sports | None |
| Manufacturer | Bayer Zydus Pharma Pvt. Ltd. |
| Packing | 28 tabs/blister |
|
Opinie
Na razie nie ma opinii o produkcie.